Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) FCF Margin (2016 - 2018)

Armata Pharmaceuticals' FCF Margin history spans 6 years, with the latest figure at 1064.09% for Q4 2018.

  • For Q4 2018, FCF Margin rose 1299909.0% year-over-year to 1064.09%; the TTM value through Dec 2018 reached 1734.94%, up 977842.0%, while the annual FY2024 figure was 708.15%, 362812.0% up from the prior year.
  • FCF Margin for Q4 2018 was 1064.09% at Armata Pharmaceuticals, up from 708.47% in the prior quarter.
  • Across five years, FCF Margin topped out at 1064.09% in Q4 2018 and bottomed at 11935.0% in Q4 2017.
  • The 5-year median for FCF Margin is 3173.27% (2014), against an average of 4876.96%.
  • The largest annual shift saw FCF Margin tumbled -8688350bps in 2014 before it soared 1299909bps in 2018.
  • A 5-year view of FCF Margin shows it stood at 3173.27% in 2014, then increased by 28bps to 2294.12% in 2015, then tumbled by -199bps to 6868.18% in 2016, then crashed by -74bps to 11935.0% in 2017, then soared by 109bps to 1064.09% in 2018.
  • Per Business Quant, the three most recent readings for ARMP's FCF Margin are 1064.09% (Q4 2018), 708.47% (Q3 2018), and 11935.0% (Q4 2017).